会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Method for composite cell-based implants
    • 基于复合细胞的植入物的方法
    • US06662805B2
    • 2003-12-16
    • US09922909
    • 2001-08-06
    • Carmelita G. FrondozaDavid S. HungerfordAlan H. ShikaniAbraham J. DombDavid J. FinkLeonard Bloom
    • Carmelita G. FrondozaDavid S. HungerfordAlan H. ShikaniAbraham J. DombDavid J. FinkLeonard Bloom
    • A61B1900
    • A61L27/3817A61F2/08A61K9/0024A61K9/1652A61K9/5036A61K35/12A61K47/36A61L27/3633A61L27/3641A61L27/3804A61L27/3813A61L27/3839A61L27/3852C08B15/005C08B33/00C08B37/00C08B37/0021C08B37/006C08H1/00C08J3/12C08J2305/08C12N5/0075C12N5/0654C12N5/0655C12N2500/02C12N2531/00C12N2533/70C12N2533/72
    • This invention is a method for the implantation of a combination of cells or cell-microcarrier aggregates wherein one component comprises a solid implantable construct and a second component comprises an injectable formulation. For example, in one embodiment, the solid implant may be first implanted to fill the majority of the cavity receiving the implant, and then cells or cell-microcarrier aggregates in an injectable format, with or without the addition of gelling materials to promote rapid gelling in situ, may be injected into spaces surrounding the solid implant in order to secure the solid implant in the site and/or to promote rapid adherence and/or integration of the solid implant to surrounding tissues. Also contemplated in this embodiment is that the cellular composition of the injectable component may differ from that of the solid component. For example, the solid implant may result from the culturing of chondrocytes on microcarriers or scaffolds, thereby resulting in an implant having cartilage-like properties, whereas the injectable cells or aggregates may result from the culturing of stem cells, resulting thereby in cells capable of producing cells of a chondrogenic, fibroblastic, myoblastic or osteoblastic phenotype. In this example, cells in the injectable aggregates may promote the fixation to or rapid integration of the solid cartilage implant into surrounding cartilage, connective tissue, muscle or bone, respectively.
    • 本发明是用于植入细胞或细胞 - 微载体聚集体的组合的方法,其中一个组分包含固体可植入构建体,第二组分包含可注射制剂。 例如,在一个实施例中,可以首先植入固体植入物以填充接收植入物的空腔的大部分,然后填充可注射形式的细胞或细胞 - 微载体聚集体,伴随或不添加胶凝材料以促进快速凝胶化 原位可以被注入到固体植入物周围的空间中,以便将固体植入物固定在部位中和/或促进固体植入物与周围组织的快速粘附和/或整合。 在该实施方案中也考虑到可注射组分的细胞组成可能不同于固体组分。 例如,固体植入物可以由微载体或支架上的软骨细胞的培养产生,从而导致具有软骨样特性的植入物,而可注射细胞或聚集体可能是由培养干细胞导致的,从而导致能够 产生软骨形成,成纤维细胞,成肌细胞或成骨细胞表型的细胞。 在该实施例中,可注射聚集体中的细胞可以促进将固体软骨植入物固定或者快速整合到周围软骨,结缔组织,肌肉或骨骼中。